» Articles » PMID: 2830487

Alternative Splicing of Chicken Fibronectin in Embryos and in Normal and Transformed Cells

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1987 Dec 1
PMID 2830487
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

To study the alternative splicing of fibronectin during embryogenesis and oncogenic transformation, we isolated cDNA clones of chicken fibronectin. The partial amino acid sequence deduced from sequencing of these clones showed that, overall, chicken fibronectin is approximately 80% identical with mammalian fibronectins. However, two of the three known regions of alternative splicing differed from this average. The V region was significantly more divergent, and RNA from embryonic chicken liver showed a pattern of V exon splicing which was distinct from that seen in human or rat fibronectins. In contrast, the EIIIB segment was very highly conserved (96%). As in mammals, this segment and another (EIIIA) were alternatively spliced in a cell-type-specific fashion. EIIIA+ and EIIIB+ species were almost absent in liver but predominated in total embryo RNA at all times from 2.5 to 11 days postfertilization. We also examined the possible contributions of fibronectin splicing and integrin receptor expression to the loss of fibronectin on oncogenic transformation. We detected little change in fibronectin splicing, other than a slight increase in representation of EIIIB+ species in fibroblasts after transformation by Rous sarcoma virus. It was also established that the overall reduction in fibronectin mRNA level observed after transformation was not accompanied by a decrease in integrin mRNA levels, indicating that fibronectin and integrin receptors are not coordinately regulated at the transcriptional level.

Citing Articles

Adaptation of the group A Streptococcus adhesin Scl1 to bind fibronectin type III repeats within wound-associated extracellular matrix: implications for cancer therapy.

McNitt D, Choi S, Allen J, Hames R, Weed S, Van De Water L Mol Microbiol. 2019; 112(3):800-819.

PMID: 31145503 PMC: 6736723. DOI: 10.1111/mmi.14317.


Multifaced Roles of the αvβ3 Integrin in Ehlers-Danlos and Arterial Tortuosity Syndromes' Dermal Fibroblasts.

Zoppi N, Chiarelli N, Ritelli M, Colombi M Int J Mol Sci. 2018; 19(4).

PMID: 29587413 PMC: 5979373. DOI: 10.3390/ijms19040982.


Interepithelial signaling with nephric duct is required for the formation of overlying coelomic epithelial cell sheet.

Yoshino T, Saito D, Atsuta Y, Uchiyama C, Ueda S, Sekiguchi K Proc Natl Acad Sci U S A. 2014; 111(18):6660-5.

PMID: 24753584 PMC: 4020081. DOI: 10.1073/pnas.1316728111.


EDA-containing fibronectin increases proliferation of embryonic stem cells.

Losino N, Waisman A, Solari C, Luzzani C, Fernandez Espinosa D, Sassone A PLoS One. 2013; 8(11):e80681.

PMID: 24244705 PMC: 3828241. DOI: 10.1371/journal.pone.0080681.


Fibronectins, their fibrillogenesis, and in vivo functions.

Schwarzbauer J, DeSimone D Cold Spring Harb Perspect Biol. 2011; 3(7).

PMID: 21576254 PMC: 3119908. DOI: 10.1101/cshperspect.a005041.


References
1.
SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View

2.
Schwarzbauer J, Patel R, Fonda D, Hynes R . Multiple sites of alternative splicing of the rat fibronectin gene transcript. EMBO J. 1987; 6(9):2573-80. PMC: 553677. DOI: 10.1002/j.1460-2075.1987.tb02547.x. View

3.
Fagan J, Sobel M, Yamada K, de Crombrugghe B, Pastan I . Effects of transformation on fibronectin gene expression using cloned fibronectin cDNA. J Biol Chem. 1981; 256(1):520-5. View

4.
Richter H, Seidl M, HORMANN H . Location of heparin-binding sites of fibronectin. Detection of a hitherto unrecognized transamidase sensitive site. Hoppe Seylers Z Physiol Chem. 1981; 362(4):399-408. DOI: 10.1515/bchm2.1981.362.1.399. View

5.
Hayashi M, Yamada K . Differences in domain structures between plasma and cellular fibronectins. J Biol Chem. 1981; 256(21):11292-300. View